Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Striatal and hippocampal contributions to value-based learning in adolescence
    Published on 2025-10-09
    10 months ago
  • Transdiagnostic prevention in youth mental health, Part II: interventions
    Published on 2025-10-07
    10 months ago
  • Transcription factors Lef1 and Rest stimulate recovery from depressive states
    Published on 2025-10-07
    10 months ago
  • Early-life neural correlates of behavioral inhibition and anxiety risk
    Published on 2025-10-04
    10 months ago
  • In Memoriam Peter Charles Whybrow, M.D., D.P.M., M.B., F.R.C.P
    Published on 2025-10-04
    10 months ago
  • Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M1 and M4 receptors
    Published on 2025-10-04
    10 months ago
  • The genetics of cannabis lifetime use
    Published on 2025-10-03
    10 months ago
« Previous 1 … 35 36 37 38 39 … 143 Next »
Journal of Psychopharmacology
  • Challenges for switching central nervous system and psychiatric medication products: A review of the literature
    Published on 2025-01-31
    1 year ago
  • Systemic bupropion treatment reduces long-access cocaine self-administration in male and female rats
    Published on 2025-01-30
    1 year ago
  • Toward effective oxytocin interventions in autism: Overcoming challenges and harnessing opportunities
    Published on 2025-01-25
    2 years ago
  • Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review
    Published on 2025-01-20
    2 years ago
  • A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
    Published on 2025-01-20
    2 years ago
  • Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study
    Published on 2025-01-07
    2 years ago
  • Haloperidol dopamine receptor occupancy and antagonism correspond to delirium agitation scores and EPS risk: A PBPK-PD modeling analysis
    Published on 2025-01-04
    2 years ago
« Previous 1 … 35 36 37 38 39 … 150 Next »
European Neuropsychopharmacology
  • Risk of mortality and complications in people with depressive disorder and diabetes mellitus: A 20-year population-based propensity score-matched cohort study
    Published on 2024-11-30
    2 years ago
  • Risk of mortality and complications in patients with severe mental illness and co-occurring diabetes mellitus: A systematic review and meta-analysis
    Published on 2024-11-29
    2 years ago
  • Clinical sleep staging for insomnia disorder
    Published on 2024-11-29
    2 years ago
  • Cannabis use and psychosis: evidence and new clinical features of a new epidemic
    Published on 2024-11-29
    2 years ago
  • Rare Genetic variation in schizophrenia: Are the most obvious ‘druggable pathways’ hiding in plain sight?
    Published on 2024-11-29
    2 years ago
  • Valproate’s impact on future generations — A call for stricter guidelines for maternal and paternal use
    Published on 2024-11-29
    2 years ago
  • Mitochondrial DNA copy number is significantly increased in bipolar disorder patients and is correlated with long-term lithium treatment
    Published on 2024-11-29
    2 years ago
« Previous 1 … 35 36 37 38 39 … 168 Next »

   Pharma Pub